MAHASKA HEALTH PARTNERSHIP — History
CCN 161379 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$76M
Latest Revenue (FY2022)
+14.6%
Revenue CAGR (3yr)
-3.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $58M | $70M | $76M | +8.7% | +14.6% |
| Operating Expenses | $70M | $68M | $79M | +15.4% | +6.1% |
| Operating Margin | -21.1% | 2.1% | -3.9% | -283.6% | +0.0% |
| Net Income | $-12M | $1M | $-3M | -299.6% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 4,466 | 4,499 | 5,329 | +18.4% | +9.2% |
| Medicare Day % | 55% | 51% | 45% | -10.8% | -9.5% |
| Medicaid Day % | 0% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +31.2% ($58M → $76M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+14.6%
This Hospital
+7.6%
State Avg
Latest Margin
-3.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $85M | 4.7% |
| FY2024 (proj) | $94M | 13.3% |
| FY2025 (proj) | $103M | 22.0% |